Haven't heard about the Monkey's (yet)...however, I did see this:
"All five human participants transitioned from daily combination ART to self-administered weekly subcutaneous (SC) injections of 350 mg or 700 mg Leronlimab and to date all participants have sustained virologic suppression for over seven years"
Market Data 
Markets 
